UK biotech buoyant, despite waves from across the Atlantic

6th October 2015

UK biotech buoyant, despite waves from across the AtlanticAndrew McConaghie

Emerging UK biotech firms with strong science look set for a bright future, despites fear about US pricing and the 'bubble' bursting.A resurgent UK biotech sector looks set to finish... Read more

Promoted tweets negatively impacting medical conferences

5th October 2015

Promoted tweets negatively impacting medical conferencesSilja Chouquet

In its bid to satisfy investors with returns on paid advertising, Twitter is damaging genuine engagement, while pharma's buying power is quoshing the opportunity for balanced conversations, says Silja Chouquet.2015... Read more

Roche bemoans price distortion and 'Big Bad Pharma' attacks

2nd October 2015

Roche bemoans price distortion and 'Big Bad Pharma' attacksAndrew McConaghie

Just how much does Kadcyla cost in the UK? Roche tells Andrew McConaghie that inaccurate reports of its price have distorted the debate.Just as US pharma is once again mired... Read more

The effects of smoking on people with HIV

1st October 2015

The effects of smoking on people with HIVDavid Rowlands

David Rowlands examines why smoking is a particularly serious health threat for people living with HIV and explores a range of interventions and the views of the community based on... Read more


More firms awarded contracts for UK's genomics initiative

6th October 2015

More firms awarded contracts for UK's genomics initiativePhil Taylor

Genomics England has awarded contracts to more private companies to help accelerate the 100,000 Genomes Project.Launched in December 2012, the ambitious project aims to improve understanding of the role of genes in rare diseases, cancers... Read more

BMS fined $14 million for bribery in China

6th October 2015

BMS fined $14 million for bribery in ChinaAndrew McConaghie

Bristol-Myers Squibb (BMS) has been caught giving bribes and inducements to health care providers (HCP) in China, and must pay $14 million to US authorities.The charges have been brought against... Read more

UK doctors feel 'misunderstood' by pharma

5th October 2015

UK doctors feel 'misunderstood' by pharmaPhil Taylor

Pharma companies will have to work harder to build positive relationships with general practitioners in England's NHS and shake off their 'bad pharma' reputation, according to a new survey.Four out of 10 GPs polled... Read more

BMS gets green light in US for Opdivo/Yervoy combination

2nd October 2015

BMS gets green light in US for Opdivo/Yervoy combinationPhil Taylor

The US FDA has approved the combined use of Bristol-Myers Squibb's melanoma drugs Yervoy and Opdivo, a highly effective but pricey treatment regimen.This is the first time that two immuno-oncology... Read more

Audio & Video

LIVE WEBINAR: Customer data is the lifeb…

Veeva webinar 29Oct2


Findings from the Veeva 2015 European Life Sciences Survey

Customer data challenges are among the most vexing and pervasive that life... View more

Live webinar: Improving patient adherenc…

West webinar 17Sept


The best drug, in the best container, with the best delivery device is useless if the patient does not take the... View more

Available on demand: Accelerate the suc…


Please click on the banner above to see the webinar.

Join this webinar to hear case studies and key success factors in using global... View more

Available on demand: Changing behaviour:…

BrightTALK holding slide 4 22June


Understanding your customers is fundamental to effective communication. Current segmentation strategies draw on ever more detailed information... View more

White Papers

Next-generation brand launches: Global h…

Next-generation brand launches: Global health data and insights can transform your business

Life Sciences companies face challenges today in achieving their revenue forecast and return on investment from brand launches. Much of this is driven by access to critical data, and their ability to... View info

Patient centricity: What it means and wh…

Patient centricity: What it means and why it’s important to have patients at the centre of our thinkingDuncan Cantor

Having clear parameters of patient‑centricity that can be measured year-on-year enables Boehringer Ingelheim UK to know if it is moving in the right direction and to set targets for what... View info

Successful biopharma product launches de…

Successful biopharma product launches depend upon market insights – driving competitive advantage through innovationChristian Marcazzo & Robin Munro

A major competitive advantage can be gained by companies that unlock the value hidden in the vast quantity of healthcare data available today – particularly that presented by real-world data.... View info

Optimising patient outcomes through phys…

Optimising patient outcomes through physician educationDr James Quekett

Physician education is undergoing a massive change as the volume of advances in therapies and practices increases and the use of digital channels facilitates new forms of scientific exchange. This white... View info

Further News & Articles

Clinton ad keeps drug pricing - and Shkreli - in the spotlight

Presidential candidate Hillary Clinton can thank Turing Pharmaceuticals' chief executive Martin Shkreli for deli... Read more


Boehringer hails ‘landmark year’ in respiratory

Of the four new products it has launched in 12 months, Boehringer Ingelheim (BI) believes Spiolto (tiotropium/ol... Read more


Breast cancer charity calls on Roche to drop price of Kadcyla

Roche is being called on to drop the price of its breast cancer drug Kadcyla in the UK so that patients can keep... Read more


Surgeons carry out ground-breaking stem cell therapy for AMD

A stem cell therapy that could restore vision in patients with age-related macular degeneration (AMD), a leading... Read more


Doctors want pharma to provide 360-degree service

Cost and time constraints mean doctors want pharma's support to treat the patient in front of them now, as well a... Read more


Breast cancer drug Perjeta launched for early use – but UK access uncertain

Roche's Perjeta has been launched today in the UK for use in women with HER2-positive breast cancer before su... Read more